Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>Events>This Event
  Events - December 2013

Advances in Electrophysiology Europe, 2013 – A Spotlight on Ion Channel Research – Highlighting Automated Physiology

10 Dec 2013 - 10 Dec 2013 - Saffron Walden, Cambridge, UK

Bookmark and Share

Advances in drug discovery technologies now allow ion channels to be significantly more promising targets for drug discovery. This meeting has been structured to focus on recent developments in patch clamp, which have revolutionised the use of electrophysiology as a tool for drug discovery and functional screening. An authoritative panel of experienced pharmaceutical industry scientists and academics has been assembled for this meeting that will have a special emphasis upon automated electrophysiology.

Professor David Brown, UCL, UK and Dr Edward Stevens, Pfizer Neusentis, UK will give the keynote presentations. Professor David Brown will discuss his far-reaching research into the regulation of ion channels that control neural excitability, with a special emphasis on his work with the Kv7 potassium channel. Drawing upon his extensive knowledge of the drug discovery industry both in CRO’s and pharmaceutical companies, Dr Edward Stevens will review the contribution that automated electrophysiology is making to drug discovery and development.

Speakers will then discuss the development and potential of these new technologies, present experimental results obtained with these systems and debate the potential impact of current technologies and future developments.

These presentations will include data from platforms including the IonWorks Barracuda®, IonWorks® Quattro™, PatchXpress® and IonFlux™ instrumentation:

  • Matthew Bridgland-Taylor, AstraZeneca, UK - Exploitation of the IonWorks Barracuda Automated Electrophysiology Platform to Improve Assessment of Cardiac Liability
  • Kelly Gatfield, GlaxoSmithKline, UK - Development of IonWorks Barracuda assays for use in early stage safety profiling
  • Gary Clarke, BioFocus DPI, UK - Ion Channel Drug Discovery: Case Study Utilising Automated Electrophysiology
  • Mark McPate, Novartis, UK - Investigation of the TRPC Channel using the IonWorks Quattro
  • Oliver Leven, GeneData, Switzerland - Genedata Screener for Automated Patch Clamping

Further information
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos